SARS-CoV-2 and Its Variants: The Pandemic of Unvaccinated

SARS-CoV-2 and Its Variants: The Pandemic of Unvaccinated

Bibliographic Details
Main Authors:	Fabrizio Angius, Giuseppe Pala, Aldo Manzin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Microbiology
Subjects:	SARS-CoV-2 mutants vaccination effectiveness pandemic control measures COVID-19 handling concerning variants
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2021.749634/full

Similar Items

Commentary: Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2
by: Sara Haddadi, et al.
Published: (2021-09-01)

SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
by: Thi Loi Dao, et al.
Published: (2021-06-01)

Analysis of SARS-CoV-2 Spike Protein Variants with Recombinant Reporter Viruses Created from a Bacmid System
by: Cordsmeier, A., et al.
Published: (2023)

Characterization of a Novel SARS-CoV-2 Genetic Variant with Distinct Spike Protein Mutations
by: Anna Gladkikh, et al.
Published: (2021-05-01)

Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients
by: Xufang Deng, et al.
Published: (2021-09-01)

Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients
by: Claudia Maria Trombetta, et al.
Published: (2021-07-01)

Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
by: Rana Abdelnabi, et al.
Published: (2021-06-01)

Antiviral Effect of Budesonide against SARS-CoV-2
by: Natalie Heinen, et al.
Published: (2021-07-01)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
by: Gabriele Anichini, et al.
Published: (2021-05-01)

Early detection of P.1 variant of SARS-CoV-2 in a cluster of cases in Salvador, Brazil
by: Isadora Cristina de Siqueira, et al.
Published: (2021-07-01)

The Coronavirus SARS-Cov-2: the Complexity of Infection Pathogenesis, the Search of Vaccines and Possible Future Pandemics
by: E. P. Kharchenko
Published: (2020-07-01)

Mutation Signatures and In Silico Docking of Novel SARS-CoV-2 Variants of Concern
by: Nariman Shahhosseini, et al.
Published: (2021-04-01)

A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel
by: Neta S. Zuckerman, et al.
Published: (2021-06-01)

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
by: Monika Strengert, et al.
Published: (2021-08-01)

Key SARS-CoV-2 Mutations of Alpha, Gamma, and Eta Variants Detected in Urban Wastewaters in Italy by Long-Read Amplicon Sequencing Based on Nanopore Technology
by: Giuseppina La Rosa, et al.
Published: (2021-09-01)

Interactions of the Receptor Binding Domain of SARS-CoV-2 Variants with hACE2: Insights from Molecular Docking Analysis and Molecular Dynamic Simulation
by: Ismail Celik, et al.
Published: (2021-09-01)

Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar
by: Mohammad R. Hasan, et al.
Published: (2021-11-01)

Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants
by: Ahlam Chaqroun, et al.
Published: (2021-06-01)

Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England
by: Swapnil Mishra, et al.
Published: (2021-09-01)

An overview of SARS-COV-2 epidemiology, mutant variants, vaccines, and management strategies
by: Tahmeena Farooqi, et al.
Published: (2021-10-01)

Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case
by: Bradley A Connor, et al.
Published: (2021-09-01)

Observations on the current outbreak of the SARS-CoV-2 Delta Variant in Sydney
by: Rick Nunes-Vaz, et al.
Published: (2021-07-01)

High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern
by: Andres Moreira-Soto, et al.
Published: (2021-09-01)

A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
by: Chang, C.-S, et al.
Published: (2022)

SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines
by: Abbas Khan, et al.
Published: (2021-11-01)

COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy
by: Giuseppe Novelli, et al.
Published: (2021-05-01)

SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, Northeast Brazil, February 2021
by: Carolina Kymie Vasques Nonaka, et al.
Published: (2021-10-01)

First Detection of SARS-CoV-2 B.1.1.7 Variant of Concern in an Asymptomatic Dog in Spain
by: Sandra Barroso-Arévalo, et al.
Published: (2021-07-01)

Complementation of contact tracing by mass testing for successful containment of beta COVID-19 variant (SARS-CoV-2 VOC B.1.351) epidemic in Hong Kong
by: Vincent Chi-Chung Cheng, et al.
Published: (2021-12-01)

Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants
by: Ballesteros-Sanabria, L., et al.
Published: (2022)

Temporal Dominance of B.1.1.7 over B.1.354 SARS-CoV-2 Variant: A Hypothesis Based on Areas of Variant Co-Circulation
by: Evangelia Georgia Kostaki, et al.
Published: (2021-04-01)

Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants
by: Rafael Bayarri-Olmos, et al.
Published: (2021-10-01)

COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
by: Renuka Raman, et al.
Published: (2021-07-01)

Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
by: Ashlesha Deshpande, et al.
Published: (2021-06-01)

An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era
by: Alejandro Pascual-Iglesias, et al.
Published: (2021-08-01)

COVID-19 and SARS-CoV-2 Variants: Current Challenges and Health Concern
by: Md. Zeyaullah, et al.
Published: (2021-06-01)

A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virus
by: Cai He, et al.
Published: (2021-09-01)

Health system impacts of SARS-CoV − 2 variants of concern: a rapid review
by: Boulos, L., et al.
Published: (2022)

Vaccination of cats with Sad23L-nCoV-S vaccine candidate against major variants of SARS-CoV-2
by: Li, C., et al.
Published: (2022)

Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization
by: Cheng, L., et al.
Published: (2022)